| ||||
| ||||
ISSN: 0344-5704 (printed version)
ISSN: 1432-0843 (electronic version)
Jeff D. Moore, Bruce J. Dezube, Parkash Gill, Xiao-Jian Zhou, Edward P.
Acosta, Jean-Pierre Sommadossi:
Phase
I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl)
fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's
sarcoma
Cancer Chemother Pharmacol 46 (2000) 3, 173-179
Article
in PDF format (118 KB)
Sotaro Sadahiro, Shigeru Ohki, Shigeki Yamaguchi, Toshiki Takahashi,
Yoshimasa Otani, Satoshi Tsukikawa, Takuya Yamamura, Shoji Takemiya, Hideaki
Nagasaki, Kiyoshi Nishiyama, Tsuneo Fukushima, Yoshiki Hiki, Susumu Yamaguchi,
Kaoru Kumada, Hiroshi Shimada, Toshio Mitomi, Hiroyasu Makuuchi:
Feasibility
of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant
chemotherapy for colorectal cancer
Cancer Chemother Pharmacol
46 (2000) 3, 180-184
Article
in PDF format (85 KB)
Sujata Vaidyanathan, Mehdi Boroujerdi:
Effect
of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity
of doxorubicin in female rats
Cancer Chemother Pharmacol 46
(2000) 3, 185-192
Article
in PDF format (151 KB)
Philip W. Wills, Robert Hickey, Linda Malkas:
Ara-C
differentially affects multiprotein forms of human cell DNA
polymerase
Cancer Chemother Pharmacol 46 (2000) 3,
193-203
Article
in PDF format (208 KB)
Saad Akhtar, Robert A. Beckman, Diane R. Mould, Edward Doyle, Scott Z.
Fields, Jonathan Wright:
Pretreatment
with ranitidine does not reduce the bioavailability of orally administered
topotecan
Cancer Chemother Pharmacol 46 (2000) 3,
204-210
Article
in PDF format (115 KB)
Akinobu Kurita, Shoichi Kado, Norimasa Kaneda, Masaharu Onoue, Shusuke
Hashimoto, Teruo Yokokura:
Modified
irinotecan hydrochloride (CPT-11) administration schedule improves induction of
delayed-onset diarrhea in rats
Cancer Chemother Pharmacol 46
(2000) 3, 211-220
Article
in PDF format (263 KB)
Deborah W. Knapp, Nita W. Glickman, William R. Widmer, Dennis B. DeNicola,
Larry G. Adams, Thomas Kuczek, Patty L. Bonney, Amalia E. DeGortari, Connie Han,
Lawrence T. Glickman:
Cisplatin
versus cisplatin combined with piroxicam in a canine model of human invasive
urinary bladder cancer
Cancer Chemother Pharmacol 46 (2000) 3,
221-226
Article
in PDF format (89 KB)
D. Ouellet, A. P. Periclou, R. D. Johnson, J. R. Woodworth, R. L.
Lalonde:
Population
pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with
cancer
Cancer Chemother Pharmacol 46 (2000) 3, 227-234
Article
in PDF format (154 KB)
Osama M. Ashour, Fardos N. M. Naguib, Naganna M. Goudgaon, Raymond F.
Schinazi, Mahmoud H. el Kouni:
Effect
of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on
plasma concentration of uridine released from
2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine
rescue in chemotherapy
Cancer Chemother Pharmacol 46 (2000) 3,
235-240
Article
in PDF format (106 KB)
Hiroshi Mese, Akira Sasaki, Shuko Nakayama, Rafael E. Alcalde, Tomohiro
Matsumura:
The
role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in
cisplatin-resistant A431 cell line
Cancer Chemother Pharmacol
46 (2000) 3, 241-245
Article
in PDF format (113 KB)
William C. Rose, Francis Y. F. Lee, Jerzy Golik, John Kadow:
Preclinical
oral antitumor activity of BMS-185660, a paclitaxel derivative
Cancer
Chemother Pharmacol 46 (2000) 3, 246-250
Article
in PDF format (99 KB)
Robert Pelley, Ram Ganapathi, Laura Wood, Lisa Rybicki, Denise McLain, G.
Thomas Budd, David Peereboom, Thomas Olencki, Ronald M. Bukowski, G. Thomas
Budd:
short
communication: A phase II pharmacodynamic study of pyrazoloacridine in
patients with metastatic colorectal cancer
Cancer Chemother Pharmacol
46 (2000) 3, 251-254
Article
in PDF format (76 KB)
|
